Researchers presenting at a nuclear medicine meeting found that Amyvid, an amyloid-binding tracer used in brain imaging, can also detect cardiac amyloidosis, which can lead to cardiovascular disease. The research included three patients with mutated forms of transthyretin amyloid and five patients with light-chain amyloidosis. Findings point to "the potential for a clinical method of diagnosis in the quantification of myocardial amyloid load, which warrants further investigation," lead author Dr. Karen Wells said.

Related Summaries